Top Markets
#1 Helium Helium +109.41%
#2 MowCat MowCat +103.90%
#3 Seeker Seeker +74.55%
#4 Pons Pons +47.43%
#5 AI XOVIA AI XOVIA +39.39%
#6 UnifAI Network UnifAI Network +33.34%
#7 Bounce Bounce +30.38%
#8 Tensor Tensor +22.88%
#9 Zylo Ecosystem Zylo Ecosystem +21.26%
#10 pipedog pipedog +20.42%
Coin of the day
Helium Helium
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Clasificación en acciones #11593
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Precio por acción
$29.06
Última sincronización: 2023-02-23
Capitalización bursátil
$682.73M
Cambio (1 día)
-0.48%
Cambio (1 año)
0.00%
País
US
Comercio CinCor Pharma, Inc. (CINC)

Categoría

Healthcare
Historial de rendimiento por dividendo de CinCor Pharma, Inc. (CINC)
Rendimiento por dividendo (TTM) de CinCor Pharma, Inc. (símbolo bursátil: CINC) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de CinCor Pharma, Inc. (CINC) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH